Digital China Health Technologies participated in a $17.1 million extension of a Congenica Series B funding that has now raised a total of $30 million. Congenica, a UK company, is developing the next generation of its Sapientia™ platform, an AI decision support system for genomics used to identify rare diseases and provide cancer management. Last year, DCHealth acquired rights to promote the Sapientia platform in China. DCHealth is the healthcare subsidiary of Digital China Holdings, a major China IT company.
Source: China Biotoday
